Weybosset Research Increases Holdings in MaxLinear

Summary

Weybosset Research & Management LLC increased its holdings in MaxLinear, Inc. (NASDAQ: MXL) by 134% in the first quarter, acquiring 124,240 shares, bringing their total to 216,971 shares. MaxLinear accounts for 0.8% of the fund’s portfolio. Other institutional investors have also adjusted their positions in MaxLinear. Analysts have mixed ratings on the stock, with an average target price of $19.06. MaxLinear reported a quarterly EPS of $(0.05) and revenue of $95.93 million, slightly above expectations. The stock opened at $11.24 with a market cap of $951.29 million.Market Beat

Impact Analysis

The event is classified at the company level because it specifically affects MaxLinear, Inc. The increased stake by Weybosset Research indicates confidence in MaxLinear’s potential, despite the mixed analyst ratings and slight earnings miss. First-order effects include potential positive sentiment from institutional endorsement, which could stabilize or increase stock prices. Second-order effects might involve increased scrutiny or interest from other investors, possibly affecting market liquidity and volatility. Investment opportunities could arise from buying MaxLinear shares while monitoring for changes in earnings performance or further institutional interest. The risks include continued negative earnings and overall market conditions impacting tech stocks.Market Beat